Jump to content

Dentsply

From Alfawiki
Adapted from the English Wikipedia article Dentsply, available under CC BY-SA 4.0Updated 24 July 2025
Dentsply Sirona Inc.
Company typePublic
IndustryDental equipment and consumables
Founded2016
Headquarters
Charlotte, North Carolina
,
United States
Area served
Worldwide (over 120 countries)
Key people
Daniel Scavilla (President and CEO, effective August 1, 2025), Simon D. Campion (former CEO), Donald Casey Jr. (former CEO)
ProductsDental laboratory instruments, dental equipment, consumables (anesthetics, plaque and gum disease prevention products, tooth polishing devices, artificial teeth), intra-oral flat panel sensors
RevenueUS$4.03 billion (2019)
Number of employees
15,000 (2023)
Websitewww.dentsplysirona.com

Dentsply Sirona Inc. is a leading American manufacturer specializing in dental equipment and consumable products, with its offerings distributed across more than 120 countries and operational facilities in 21 nations. The company's formation traces back primarily to a 1993 merger when Gendex Corporation acquired Dentsply International Inc. for $590 million.

The firm develops and produces a broad range of dental laboratory instruments and specialized equipment, emphasizing consumables such as anesthetics, products for preventing plaque and gum disease, tooth polishing devices, and artificial teeth. Additionally, Dentsply Sirona holds a prominent position in the intra-oral flat panel sensor market. Variations in product demand are influenced by regional income levels, which affect the performance of its subsidiaries worldwide.

On August 28, 2022, Simon D. Campion, previously Executive Vice President at BD, was named CEO and joined the board of directors, signaling a strategic move to enhance corporate growth. In 2018, the company received the “Top Employer” certification from an organization based in the Netherlands.

In 2019, Dentsply Sirona collaborated with the American Association for Dental Research (AADR) to co-sponsor the Student Competition for Advancing Dental Research and its Application (SCADA), aimed at fostering new talent in dental research.

The company reported revenues near US$4.03 billion in 2019 and had approximately 15,000 employees as of December 2023. Forbes ranked it #56 among America’s Best Midsize Employers in 2019, underscoring its significant market presence and positive corporate reputation.

Name

The designation Dentsply Sirona International reflects the merger of two dental technology firms: Dentsply and Sirona Dental Systems, completed in 2016.

Sirona Dental Systems

Established in 1877 in Erlangen, Germany, Sirona Dental Systems was a major contributor to dental technology prior to its integration with Dentsply.

1899–2000

Dentsply Incorporated originated as the Dentist's Supply Company in New York City in 1889, founded by Dr. Jacob Frick Franz, John Sheppard, and Dean Osborne with an initial capital of $10,000. Early growth included acquiring a Pennsylvania-based porcelain teeth manufacturer. George H. Whiteley, a ceramic expert and influential executive, pioneered innovations such as a patented platinum ring technique that minimized tooth breakage. Research efforts led to enhancements like improved denture fit and age-appropriate tooth coloration.

During the 1920s, European distributor E. de Trey & Sons became the principal marketer across Europe and the United States. To address intense competition with Ash Company, their distribution networks merged into Amalgamated Dental Company Limited. By 1925, Dentists' Supply had acquired substantial shares in Zahnfabrik, a producer of artificial teeth.

To overcome high U.S. tariffs and broaden international reach, the company established overseas subsidiaries including one in Australia that acquired Natudryl Manufacturing. The mid-20th century brought innovations such as the Dentsply Cavitron tooth cleaning system and Neolux for finishing plastic teeth surfaces. Reflecting its expanding global footprint and brand recognition, it rebranded as Dentsply International in 1969.

Growth was further driven by key acquisitions: LD Caulk Company (1963), Ransom and Randolph Company (1964), F&F Koenigkramer Company (specializing in chairs and stools), and notably Amalgamated Dental Industrial (1976), which operated Australia's largest dental supply network.

Following the reverse takeover of Gendex Corporation in 1993, Dentsply became publicly traded on the NASDAQ. The company briefly owned Eureka X-Ray Inc., a manufacturer of medical X-ray tubes complementing Gendex’s X-ray system production, before divesting it in 1994. That same year saw the bankruptcy of Healthco, its primary U.S. distributor.

2000–present

By 2010, Dentsply's principal sales regions included Europe & CIS (40%), the United States (37%), Latin America (5%), Asia excluding CIS and Japan (5%), Canada (4%), Japan (4%), the Middle East & Africa (3%), and Australia (2%). The company commanded a dominant share within the $4.0 billion dental restorative market.

In June 2011, Dentsply expanded its portfolio by acquiring Astra Tech, the third-largest global manufacturer of dental implants, from AstraZeneca for $1.8 billion. This deal boosted revenues by 25%, adding $535 million. However, it also resulted in a 147% rise in long-term debt and a 146% increase in total assets, while net income fell by 7.4% due to costs related to the acquisition and restructuring efforts.

The significance of international markets grew steadily, representing 67% of total revenue in 2013 compared to 63% in 2011. In 2012, all sales growth of 16.2% was attributable to acquisitions, with Europe experiencing a 27.5% increase, the U.S. rising by 13.8%, and other regions expanding by 15.9%. Dental products accounted for 88% of net sales, with consumable medical devices comprising the balance.

On February 29, 2016, Dentsply completed a $14.5 billion merger with Sirona Dental Systems, creating a combined entity that integrated Dentsply’s consumables business with Sirona’s dental equipment operations.

In October 2017, CEO Jeffrey Slovin, executive chairman Bret Wise, and president Christopher Clark all stepped down. Donald Casey Jr., previously CEO of Cardinal Health’s Medical Segment, was appointed as CEO in February 2018.

April 2022 saw the removal of CEO Donald Casey; John Groetelaars took over as interim CEO until Simon Campion was appointed as permanent CEO in September 2022. Meanwhile, former CEO Casey and CFO Jorge Gomez became subjects of an SEC inquiry regarding allegations of securities fraud.

In June 2023, the Yale School of Management highlighted that Dentsply Sirona maintained its business activities in Russia despite widespread corporate exits following the invasion of Ukraine, raising questions about the company’s ethical stance and social responsibility.

On July 21, 2025, Dentsply Sirona announced that Daniel Scavilla would assume the role of President and CEO effective August 1, 2025, succeeding Simon Campion.

See also

External links